Zia, Hamid
Zia, Hamid was paid $1.76M by Medicaid between Feb 2018 and Nov 2024, across 147 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 18% of everything it billed.
PEORIA, IL 61637
Next to other Student in an Organized Health Care Education/Training Program providers in Illinois
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,819 | $104K | |
| 2019 | 34,635 | $200K | |
| 2020 | 28,977 | $197K | |
| 2021 | 32,754 | $379K | |
| 2022 | 32,949 | $326K | |
| 2023 | 41,571 | $334K | |
| 2024incomplete | 41,775 | $219K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 18% | 5,711 | 4,667 | $318K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 6.6% | 473 | 464 | $116K |
| 80053 | Comprehensive metabolic panel | 6.6% | 22,987 | 18,722 | $116K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.9% | 30,128 | 22,315 | $86K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.7% | 3,817 | 3,690 | $82K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.7% | 3,813 | 3,687 | $82K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.9% | 1,499 | 1,429 | $68K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.7% | 1,426 | 1,298 | $48K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.7% | 6,063 | 5,736 | $48K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.6% | 1,904 | 1,645 | $45K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.3% | 1,057 | 947 | $40K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.2% | 514 | 503 | $39K |
135 more codes
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.0% | 7,268 | $36K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.8% | 7,598 | $31K |
| 87510 | 1.6% | 2,194 | $28K | |
| 87480 | 1.6% | 2,195 | $27K | |
| 83735 | 1.5% | 7,477 | $26K | |
| 82803 | 1.4% | 2,349 | $24K | |
| 87040 | 1.1% | 2,069 | $20K | |
| 83605 | 1.1% | 3,560 | $19K | |
| 87660 | 1.1% | 2,343 | $19K | |
| 82962 | 1.0% | 9,767 | $18K | |
| 87641 | <1% | 794 | $17K | |
| 87081 | <1% | 5,911 | $17K | |
| 84484 | <1% | 3,013 | $15K | |
| 82330 | <1% | 1,850 | $15K | |
| 80061 | Lipid panel | <1% | 4,172 | $14K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 978 | $13K |
| 87186 | <1% | 2,308 | $12K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,639 | $12K |
| 85730 | <1% | 2,603 | $11K | |
| 86780 | <1% | 1,235 | $10K | |
| 85610 | <1% | 4,784 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,134 | $10K |
| 83880 | <1% | 878 | $9K | |
| 83690 | <1% | 2,616 | $9K | |
| 80069 | <1% | 1,912 | $8K | |
| 86850 | <1% | 2,714 | $8K | |
| 81025 | <1% | 3,574 | $8K | |
| 84100 | <1% | 3,379 | $7K | |
| 81001 | <1% | 5,013 | $7K | |
| 86803 | <1% | 894 | $7K | |
| 82607 | <1% | 1,217 | $7K | |
| 88189 | <1% | 128 | $7K | |
| 84439 | <1% | 1,573 | $7K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 262 | $7K |
| 86901 | <1% | 2,955 | $6K | |
| 88342 | <1% | 426 | $6K | |
| 86140 | <1% | 2,576 | $6K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 412 | $6K |
| 82728 | <1% | 1,409 | $5K | |
| 88307 | <1% | 79 | $5K | |
| 80202 | <1% | 736 | $5K | |
| 87088 | <1% | 974 | $5K | |
| 86900 | <1% | 2,937 | $5K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 240 | $5K |
| 84466 | <1% | 1,168 | $5K | |
| 85384 | <1% | 1,382 | $4K | |
| 87340 | <1% | 599 | $4K | |
| 87070 | <1% | 1,199 | $4K | |
| 82570 | <1% | 1,624 | $4K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 73 | $4K |
| 82784 | <1% | 509 | $4K | |
| 83970 | <1% | 251 | $4K | |
| 85379 | <1% | 983 | $4K | |
| 87147 | <1% | 2,180 | $4K | |
| 85027 | <1% | 1,238 | $4K | |
| 83540 | <1% | 1,097 | $3K | |
| 84702 | <1% | 748 | $3K | |
| 81003 | <1% | 3,137 | $3K | |
| 82746 | <1% | 594 | $3K | |
| 82550 | <1% | 1,036 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 386 | $3K |
| 86038 | <1% | 387 | $3K | |
| 83615 | <1% | 887 | $2K | |
| 85014 | <1% | 1,945 | $2K | |
| 80047 | <1% | 484 | $2K | |
| 85652 | <1% | 1,540 | $2K | |
| 87581 | <1% | 73 | $2K | |
| 83516 | <1% | 313 | $2K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 193 | $2K |
| 82805 | <1% | 59 | $2K | |
| 84703 | <1% | 480 | $2K | |
| 87486 | <1% | 73 | $2K | |
| 80074 | <1% | 83 | $2K | |
| 82043 | <1% | 847 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 72 | $2K |
| 88341 | <1% | 36 | $2K | |
| 87205 | <1% | 736 | $1K | |
| 82565 | <1% | 646 | $1K | |
| 80076 | <1% | 396 | $1K | |
| 84550 | <1% | 662 | $1K | |
| 84478 | <1% | 576 | $1K | |
| 86762 | <1% | 289 | $1K | |
| 87075 | <1% | 183 | $1K | |
| 87493 | <1% | 45 | $1K | |
| 84295 | <1% | 533 | $1K | |
| 84146 | <1% | 151 | $962.03 | |
| 86003 | <1% | 64 | $961.83 | |
| 85018 | <1% | 915 | $928.75 | |
| 82248 | <1% | 440 | $891.93 | |
| 86920 | <1% | 229 | $868.16 | |
| 84156 | <1% | 756 | $821.87 | |
| 87522 | Neg quan hep c or qual rna | <1% | 29 | $810.55 |
| 84132 | <1% | 489 | $806.18 | |
| 87077 | <1% | 348 | $736.68 | |
| 83655 | <1% | 135 | $735.41 | |
| 86706 | <1% | 112 | $731.65 | |
| 82247 | <1% | 298 | $718.56 | |
| 86480 | <1% | 30 | $714.20 | |
| 85045 | <1% | 532 | $662.00 | |
| 84481 | <1% | 139 | $658.16 | |
| 87536 | <1% | 15 | $616.98 | |
| 84403 | <1% | 44 | $530.88 | |
| 82785 | <1% | 113 | $488.48 | |
| 86360 | <1% | 28 | $419.22 | |
| 87807 | <1% | 79 | $392.34 | |
| 88304 | <1% | 25 | $391.01 | |
| 82947 | <1% | 344 | $385.71 | |
| 84145 | <1% | 18 | $342.20 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 30 | $323.10 |
| 80306 | <1% | 47 | $281.66 | |
| 88141 | <1% | 38 | $274.64 | |
| 80164 | <1% | 54 | $236.16 | |
| 86431 | <1% | 70 | $227.10 | |
| 82077 | <1% | 21 | $217.56 | |
| 82670 | <1% | 26 | $204.65 | |
| 80177 | <1% | 45 | $199.62 | |
| 86880 | <1% | 66 | $191.65 | |
| 87210 | <1% | 50 | $185.65 | |
| 86359 | <1% | 15 | $178.35 | |
| 82951 | <1% | 27 | $170.10 | |
| 82140 | <1% | 26 | $132.60 | |
| 85347 | <1% | 52 | $126.04 | |
| 84480 | <1% | 25 | $96.58 | |
| 86592 | <1% | 47 | $88.00 | |
| 86308 | <1% | 26 | $63.60 | |
| 82274 | <1% | 12 | $60.00 | |
| 86200 | <1% | 12 | $56.91 | |
| 85049 | <1% | 36 | $53.39 | |
| 87102 | <1% | 12 | $46.50 | |
| 82272 | <1% | 45 | $45.60 | |
| 84300 | <1% | 16 | $36.04 | |
| 81015 | <1% | 30 | $35.37 | |
| 82950 | <1% | 12 | $27.96 | |
| 82009 | <1% | 13 | $20.54 | |
| 84157 | <1% | 15 | $13.80 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.